AllJournalThesisConferenceNewspaperPatentStandardYear BookBook|ResearcherProject
all languages  Chinese Only  Other Languages
Author:Yael Feferman , Shanel Bhagwandin , Joseph Kim ...
Data Source:[J].Annals of Surgical Oncology(IF 4.12), 2017, Vol.24 (13), pp.3831-3836Springer
Abstract:During heated intraperitoneal chemotherapy (HIPEC), neutropenia rates of 20 to 40% have been reported when mitomycin C (MMC) is dosed by weight or body surface area (BSA). This study investigated the authors’ HIPEC experience using a fixed 40-mg dose of MMC, per consensus gu...
Author:Kotaro Yamashita , Hiroshi Miyata , Tomoki Makino ...
Data Source:[J].Annals of Surgical Oncology(IF 4.12), 2017, Vol.24 (13), pp.4025-4032Springer
Abstract:Autophagy plays a major role in cellular homeostasis and is implicated in cancer progression. Damaged mitochondria are scavenged and eliminated by mitochondrial autophagy, referred to as mitophagy, which can promote cancer cell survival. This study investigated the expression and...
Author:Suguru Hasegawa , Saori Goto , Takuya Matsumoto ...
Data Source:[J].Annals of Surgical Oncology(IF 4.12), 2017, Vol.24 (12), pp.3587-3595Springer
Abstract:This prospective multicenter phase 2 study aimed to evaluate the feasibility and efficacy of neoadjuvant chemotherapy (NAC) without radiotherapy for locally advanced rectal cancer (LARC).
Author:Simone Manfredelli , Jean-Baptiste Delhorme , Aïna Venkatasamy ...
Data Source:[J].Annals of Surgical Oncology(IF 4.12), 2017, Vol.24 (11), pp.3324-3330Springer
Abstract:To evaluate the impact of a feeding jejunostomy (FJ) on the preoperative management of patients with an oesogastric adenocarcinoma (OGA).
Author:C. Bisschop , T. H. van Dijk , J. C. Beukema ...
Data Source:[J].Annals of Surgical Oncology(IF 4.12), 2017, Vol.24 (9), pp.2632-2638Springer
Abstract:In a Dutch phase II trial conducted between 2006 and 2010, short-course radiotherapy followed by systemic therapy with capecitabine, oxaliplatin, and bevacizumab as neoadjuvant treatment and subsequent radical surgical treatment of primary tumor and metastatic sites was evaluated...

Being retrieved, please wait for a moment...

International Cooperation:cnki.scholar@cnki.net, +86-10-82896619   Feedback:scholar@cnki.net

×